J&J falls despite a beat-and-raise quarter. Why we’re raising our price target anyways
Johnson & Johnson's quarter was imperfect, but enough is going right to validate our ownership of the stock.
The Source
CNBC
US
Analysis: Fed Chairman Warsh faces an inflation credibility test after Congress hearings
CNBC·43m ago·3 min read
Business
World Cup gave bars and restaurants a needed boost as consumers flash warning signs, Fed says
CNBC·1h ago·3 min read
Business
United earnings top estimates but airline expects $6 billion in added fuel costs
CNBC·1h ago·3 min read
US
Amazon senior cloud executive departs after 18 years
CNBC·4h ago·3 min read
Related
On this beat
Health
Years After He Quit Smoking, a Lung Cancer Scan Saved His Life
TNYT·3h ago·3 min read
Health
U.S. Citizen Tests Positive for Ebola in Democratic Republic of Congo
TNYT·4h ago·3 min read
Health
Boehringer Ingelheim Posts Sales Growth as Obesity Drug Filing Awaits
TWSJ·10h ago·3 min read
Health
Trump’s Latest Nominee for C.D.C. Director Will Face Senate Panel
TNYT·13h ago·3 min read